Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PREP | P48147 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10585129 | 1.00 | MAPT (0.36) | MAPTHPGDPREP | |
| SCHEMBL9358907 | 0.77 | POLB (0.38) | — | |
| SCHEMBL6695781 | 0.75 | MAPT (0.39) | MAPTHPGDPREP | |
| SCHEMBL10402846 | 0.74 | ELANE (0.35) | — | |
| SCHEMBL10402765 | 0.74 | ELANE (0.35) | — | |
| SCHEMBL10747693 | 0.74 | ELANE (0.35) | — | |
| SCHEMBL10553544 | 0.74 | CTSL (0.31) | MAPTHPGD | |
| SCHEMBL9313048 | 0.74 | CTSL (0.31) | MAPTHPGD | |
| SCHEMBL5857804 | 0.74 | CTSL (0.31) | MAPTHPGD | |
| SCHEMBL9423301 | 0.74 | CTSL (0.31) | MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114685554-A | Preparation method of 4AA diastereoisomer | 武汉中有药业有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685339-A | Preparation method of 4AA diastereoisomer | 武汉中有药业有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685340-A | Preparation method of 4AA diastereoisomer | 武汉中有药业有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-103613526-A | Preparation method of meropenem intermediate cyclization compound | JIANGSU HANKUO BIOLOG CO LTD | 2014-03-05 | — | — | CN | disclosed |
| US-8232389-B2 | Method for crystallization of azetidinonecarboxylic acid | KANEKA CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| US-20100298556-A1 | Method for crystallization of azetidinonecarboxylic acid | KANEKA CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| EP-2030977-A1 | IMPROVED METHOD FOR CRYSTALLIZATION OF AZETIDINONECARBOXYLIC ACID | Kaneka Corporation (JP) | 2009-03-04 | — | — | EP | disclosed |
| EP-0502464-A1 | Antibacterial condensed carbapenemes | GLAXO S.p.A. (IT) | 1992-09-09 | — | — | EP | disclosed |
| EP-0247378-B1 | PROCESS FOR PREPARING 4-ACETOXY-3-HYDROXYETHYLAZETIDIN-2-ONE DERIVATIVES | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-09-19 | — | — | EP | disclosed |
| US-4914200-A | REACTING PROTECTED BETA-LACTAM WITH ACETIC ANHYDRIDE IN ORGANIC SOLVENT CONTAINING WATER OR ACETIC ACID IN PRESENCE OF PYRIDINE COMPOUND AT LOW TEMPERATURE | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-04-03 | — | — | US | disclosed |
| EP-0247378-A1 | Process for preparing 4-acetoxy-3-hydroxyethylazetidin-2-one derivatives | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-12-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298556-A1 | Method for crystallization of azetidinonecarboxylic acid | HPD, DECR2, SRD5A2 | MAPT 3000/4885HPGD 1119/4885PREP 2071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.